Neonatal drug development addressed in FDA final guidance

Regulatory NewsRegulatory NewsBiologicsBiotechnologyChemistry, Manufacturing and Controls (CMC)Clinical TrialsNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy